삼아제약 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 황종숙, was filed 25 Aug 2025.
삼아제약: what insiders have been doing
This page follows insider dealings at 삼아제약 as filed with DART (FSS), a company from the Health Care sector. Between 1 November 2025 and 1 November 2026, 1 insider published 1 filing.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
There has been no open-market purchase by an insider of 삼아제약 for at least a year.
Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 1 filing, this issuer sits below that mark. Over the whole record (from 2021), the tally stands at 9 purchases and no sales.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- -17.9%Entry ₩17,020 · Close at T+365 ₩13,980
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- ●Executives0DART
- 1,105 sharesShareKRXDART:20250825000201Canonical exit: 23 Nov 2025 (T+90)
- 1,105 shares@ ₩18,443.7167100.0% of flowShareKRXDART:20250825000137Canonical exit: 9 Oct 2025 (T+90)
- ●Executives0DART
- ShareKRXDART:20230323001101Canonical exit: 21 Jun 2023 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ShareKRXDART:20220901000383Canonical exit: 30 Nov 2022 (T+90)
- ShareKRXDART:20220901000374Canonical exit: 30 Nov 2022 (T+90)
- ShareKRXDART:20220901000368Canonical exit: 30 Nov 2022 (T+90)
- ShareKRXDART:20220816000861Canonical exit: 14 Nov 2022 (T+90)
- ShareKRXDART:20220812000441Canonical exit: 10 Nov 2022 (T+90)
- ShareKRXDART:20211013000069Canonical exit: 11 Jan 2022 (T+90)
14 of 14 declarations
About 삼아제약
Samah Pharmaceutical is a South Korean pharmaceutical company focused on the development and manufacturing of medications. It is listed on the XKRX.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
